Common misconceptions

Common mistake
Wrong: Lambert-Eaton syndrome, like myasthenia gravis, worsens with repeated muscle use.
Right: Lambert-Eaton syndrome improves transiently with repeated use (post-tetanic potentiation) because repetitive stimulation increases ACh release, while MG worsens with use.
In MG, each nerve impulse releases ACh that binds to fewer and fewer available receptors (because antibodies have destroyed them), so repetitive use = progressive failure = worsening weakness. In Lambert-Eaton, the presynaptic VGCC antibodies impair initial ACh release, but repetitive stimulation causes calcium to accumulate presynaptically, temporarily boosting ACh output — this is post-tetanic potentiation, and it produces a transient improvement in strength. The exam will absolutely give you both options; knowing that Lambert-Eaton improves briefly with activity while MG worsens is the discriminating fact.
Common mistake
Wrong: Myasthenia gravis antibodies block presynaptic calcium channels.
Right: MG is caused by antibodies against postsynaptic nicotinic acetylcholine receptors (or MuSK), while Lambert-Eaton is caused by antibodies against presynaptic voltage-gated calcium channels.
MG antibodies hit the postsynaptic side — they target the nicotinic AChR (or less commonly MuSK, a receptor tyrosine kinase involved in NMJ organization). Lambert-Eaton is the presynaptic disease: antibodies against voltage-gated calcium channels (VGCCs) prevent calcium influx and thus impair vesicle fusion and ACh release. A clean mnemonic: MG = 'My Gravis Grabs the receptor' (postsynaptic); LEMS = 'LEMS Locks the calcium channel' (presynaptic). Getting the localization wrong will kill your answer on a two-step mechanism question.
Common mistake
Wrong: Anticholinesterase agents should be increased during myasthenic crisis.
Right: During myasthenic crisis, anticholinesterases are typically held and treatment relies on plasmapheresis or IVIG plus mechanical ventilation support.
During myasthenic crisis, the NMJ is already overwhelmed — adding more pyridostigmine risks ACh accumulation, which can paradoxically worsen weakness and cause cholinergic toxicity (SLUDGE symptoms). The acute rescue strategy is plasmapheresis (to rapidly remove circulating antibodies) or IVIG (to modulate the immune response), plus mechanical ventilation if respiratory failure is present. Anticholinesterases are typically held temporarily. Think of it as: you can't titrate your way out of a crisis; you have to clear the antibodies first.
Common mistake
Gap: Misses that ocular symptoms (ptosis, diplopia) are the most common initial presentation of MG and worsen with sustained use
MG classically presents with ptosis and diplopia (ocular muscles affected first) that worsen throughout the day, reflecting fatigable weakness.
Ocular muscles are affected earliest and most prominently in MG because they have high firing rates and fewer AChRs per motor endplate compared to limb muscles — so they hit the threshold for failure faster. Ptosis and diplopia that worsen late in the day (after sustained use) are the classic opening presentation. If a patient describes eyelid drooping that's better in the morning and worse by evening, think MG immediately. This 'worse with use, better with rest' cycle is the clinical signature of fatigable weakness.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Mechanism: Identify the specific antibody target in MG (postsynaptic nicotinic AChR, or MuSK) and understand how antibody-mediated receptor destruction at the NMJ causes fatigable weakness.
  2. Presentation: Recognize the classic MG pattern — ptosis and diplopia that worsen throughout the day, proximal limb weakness, bulbar symptoms — and know the demographic associations (young women and older men).
  3. Diagnosis: Know which antibody tests to order (anti-AChR first, then anti-MuSK if negative), how the edrophonium (Tensilon) test works, what repetitive nerve stimulation shows on EMG (decremental response), and why CT chest is needed to rule out thymoma.
  4. Crisis management: Know the distinction between myasthenic crisis (NMJ failure, respiratory compromise) and cholinergic crisis, and understand why anticholinesterases are typically held during myasthenic crisis while plasmapheresis or IVIG plus ventilatory support are used.
  5. Lambert-Eaton contrast: Distinguish MG from Lambert-Eaton syndrome by antibody target (VGCC vs. AChR), weakness pattern (improves transiently with repetition vs. worsens), associated cancer (small cell lung vs. thymoma), and EMG findings (incremental vs. decremental response).

Can you avoid these mistakes?

A 28-year-old woman presents with drooping of her left eyelid that began 2 months ago. She notices it is barely perceptible in the morning but is obvious by late afternoon. On exam, sustained upward gaze worsens the ptosis. Anti-AChR antibodies are positive. What is the next imaging study you should order and why?
A patient with known myasthenia gravis is admitted in respiratory distress. His oxygen saturation is 88% and he cannot lift his arms. The admitting intern wants to give a large dose of pyridostigmine IV. Why is this the wrong move, and what is the correct acute management?
A 55-year-old male smoker presents with proximal leg weakness that actually seems to improve slightly when he walks a few steps before worsening again. EMG shows an incremental response with high-frequency repetitive stimulation. How does this differ from myasthenia gravis mechanistically, and what cancer workup is indicated?
You administer edrophonium (Tensilon) to a patient with suspected MG and her ptosis transiently resolves. Explain the mechanism of this test — specifically why edrophonium improves symptoms, and why this test is rarely used clinically today.

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →